Skip to content
October 30, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Johnson & Johnson’s Transformative Acquisition of Intra-Cellular Therapies Delivers Significant Advances in Bipolar Disorder Treatment johnson-johnsons-transformative-acquisition-of-intra-cellular-therapies-delivers-significant-advances-in-bipolar-disorder-treatment
  • Medical Research and Clinical Trials

Johnson & Johnson’s Transformative Acquisition of Intra-Cellular Therapies Delivers Significant Advances in Bipolar Disorder Treatment

Siti Muinah September 22, 2026
New Phase III Trial Data for Caplyta Reinforces Strategic Value of $14.6 Billion Acquisition, Signaling a New...
Read More Read more about Johnson & Johnson’s Transformative Acquisition of Intra-Cellular Therapies Delivers Significant Advances in Bipolar Disorder Treatment
The “Most-Favored-Nation” Paradox: Are Trump’s Drug Pricing Deals Stalling Meaningful Reform? the-most-favored-nation-paradox-are-trumps-drug-pricing-deals-stalling-meaningful-reform
  • Treatment Innovations

The “Most-Favored-Nation” Paradox: Are Trump’s Drug Pricing Deals Stalling Meaningful Reform?

Azzam Bilal Chamdy September 22, 2026
The landscape of American pharmaceutical pricing is currently defined by a high-stakes legislative experiment. President Donald Trump’s...
Read More Read more about The “Most-Favored-Nation” Paradox: Are Trump’s Drug Pricing Deals Stalling Meaningful Reform?
Beyond the Diagnosis: Addressing the Silent Crisis of Body Image Distress in Oncology beyond-the-diagnosis-addressing-the-silent-crisis-of-body-image-distress-in-oncology
  • Clinical Oncology Education

Beyond the Diagnosis: Addressing the Silent Crisis of Body Image Distress in Oncology

Asep Darmawan September 22, 2026
For many patients, a cancer diagnosis marks the beginning of a profound, often traumatic transformation. While the...
Read More Read more about Beyond the Diagnosis: Addressing the Silent Crisis of Body Image Distress in Oncology
The Art of Presence: John Emmons and the Legacy of Shanti Project’s HIV/AIDS Volunteers the-art-of-presence-john-emmons-and-the-legacy-of-shanti-projects-hiv-aids-volunteers
  • Integrative Oncology and Holistic Care

The Art of Presence: John Emmons and the Legacy of Shanti Project’s HIV/AIDS Volunteers

Asro September 22, 2026
Introduction: Answering the Call in the Shadow of an Epidemic In 1985, the city of San Francisco...
Read More Read more about The Art of Presence: John Emmons and the Legacy of Shanti Project’s HIV/AIDS Volunteers
The Quiet Evolution: Why Yoga’s "Decline" Is Actually a Return to Form the-quiet-evolution-why-yogas-decline-is-actually-a-return-to-form
  • Integrative Oncology and Holistic Care

The Quiet Evolution: Why Yoga’s "Decline" Is Actually a Return to Form

Muslim September 22, 2026
By [Your Name/Journalistic Staff] Published September 21, 2026 The headline arrived in the digital ether with a...
Read More Read more about The Quiet Evolution: Why Yoga’s "Decline" Is Actually a Return to Form
Beyond the Surface: The Critical Science of Early Wound Assessment and Microbial Identification beyond-the-surface-the-critical-science-of-early-wound-assessment-and-microbial-identification
  • Genomics and Precision Medicine

Beyond the Surface: The Critical Science of Early Wound Assessment and Microbial Identification

Siti Muinah September 22, 2026
In the modern landscape of clinical medicine, the management of chronic and acute wounds remains a silent...
Read More Read more about Beyond the Surface: The Critical Science of Early Wound Assessment and Microbial Identification
CardiaCare Secures Oversubscribed Funding to Pioneer Non-Invasive Wearable Therapy for Atrial Fibrillation cardiacare-secures-oversubscribed-funding-to-pioneer-non-invasive-wearable-therapy-for-atrial-fibrillation
  • Treatment Innovations

CardiaCare Secures Oversubscribed Funding to Pioneer Non-Invasive Wearable Therapy for Atrial Fibrillation

Muslim September 22, 2026
In a significant milestone for cardiac health technology, Israel-based medical device innovator CardiaCare has successfully closed an...
Read More Read more about CardiaCare Secures Oversubscribed Funding to Pioneer Non-Invasive Wearable Therapy for Atrial Fibrillation
Bridging the Gap in Survivorship: Health Canada Authorizes Non-Hormonal Treatment for Breast Cancer Therapy Side Effects bridging-the-gap-in-survivorship-health-canada-authorizes-non-hormonal-treatment-for-breast-cancer-therapy-side-effects
  • Patient Advocacy and Support

Bridging the Gap in Survivorship: Health Canada Authorizes Non-Hormonal Treatment for Breast Cancer Therapy Side Effects

Iffa Jayyana September 22, 2026
TORONTO, ON — In a landmark decision for oncology and supportive care, Health Canada has announced the...
Read More Read more about Bridging the Gap in Survivorship: Health Canada Authorizes Non-Hormonal Treatment for Breast Cancer Therapy Side Effects
Simtriyo Shows Significant Efficacy in Adults with ADHD and Co-occurring Anxiety Disorders, Expanding Treatment Landscape simtriyo-shows-significant-efficacy-in-adults-with-adhd-and-co-occurring-anxiety-disorders-expanding-treatment-landscape
  • Medical Research and Clinical Trials

Simtriyo Shows Significant Efficacy in Adults with ADHD and Co-occurring Anxiety Disorders, Expanding Treatment Landscape

Laily UPN September 22, 2026
New Orleans, USA – Otsuka Pharmaceutical Development & Commercialisation and Otsuka Pharmaceutical have unveiled promising expanded Phase...
Read More Read more about Simtriyo Shows Significant Efficacy in Adults with ADHD and Co-occurring Anxiety Disorders, Expanding Treatment Landscape
Landmark ADAURA Trial Update: Eight-Year Data Confirms Osimertinib’s Role as a Cornerstone of Adjuvant NSCLC Therapy landmark-adaura-trial-update-eight-year-data-confirms-osimertinibs-role-as-a-cornerstone-of-adjuvant-nsclc-therapy
  • Clinical Oncology Education

Landmark ADAURA Trial Update: Eight-Year Data Confirms Osimertinib’s Role as a Cornerstone of Adjuvant NSCLC Therapy

Raul Delapena Setiawan September 22, 2026
In a significant milestone for thoracic oncology, long-term data from the Phase III ADAURA trial has solidified...
Read More Read more about Landmark ADAURA Trial Update: Eight-Year Data Confirms Osimertinib’s Role as a Cornerstone of Adjuvant NSCLC Therapy

Posts pagination

Previous 1 … 228 229 230 231 232 233 234 … 836 Next

Recent Posts

  • Breakthrough in Breast Cancer Treatment Offers 100% Survival Rate for Aggressive Inherited Cancers
  • France Bolsters Global Health Security with €25.5 Million Commitment to WHO
  • A Tectonic Shift: Is the Biopharma Labor Market Finally Stabilizing?
  • Finding Your Flow Without Breaking the Bank: The Definitive Guide to Budget-Friendly Yoga Mats
  • The Metabolic Frontier: Engineering Stability in the Next Generation of Multifunctional Peptides

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

breakthrough-in-breast-cancer-treatment-offers-100-survival-rate-for-aggressive-inherited-cancers
  • Medical Research and Clinical Trials

Breakthrough in Breast Cancer Treatment Offers 100% Survival Rate for Aggressive Inherited Cancers

Basiran October 29, 2026
WHO-France signing ceremony of 2023 contribution 08DEC2023
  • Breast Cancer Prevention and Lifestyle

France Bolsters Global Health Security with €25.5 Million Commitment to WHO

Laily UPN October 29, 2026
a-tectonic-shift-is-the-biopharma-labor-market-finally-stabilizing
  • Treatment Innovations

A Tectonic Shift: Is the Biopharma Labor Market Finally Stabilizing?

Suro Senen October 29, 2026
finding-your-flow-without-breaking-the-bank-the-definitive-guide-to-budget-friendly-yoga-mats
  • Integrative Oncology and Holistic Care

Finding Your Flow Without Breaking the Bank: The Definitive Guide to Budget-Friendly Yoga Mats

Jia Lissa October 29, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.